重庆睿仕康生物医药有限公司

Home
Ruishikang
- About Ruishikang
  - Company Profile
    Jointly Creating a Healthy China
  - Corporate Culture
    Listen to the voice of the CEO
- Development History
  - Honor and Qualification
    Sustainable Development
  - Memorabilia
    Excellent Corporate Citizen
- Ruishikang Global
  - Expert Advisor
    Leadership in China Business
  - Core Team
    The top leadership of the company
Product
R&D
- Research and Development Platform
- R&D Pipeline
News
- Industry News
- Ruishikang News

Contact Us 中文 EN

Ruiyi Enterprising
- Focus Areas
  - Tumor
    Ruiyi Enterprising Together to Cure Cancer
  - Vaccinum
    Vaccines make health within reach
  - Anti-Infection
    Strive for AI comprehensively
  - Inflammation and immunity
    Ruiyi Enterprising and Revitalizing
  - Rare Disease
    Rui Yi Enterprising for Love and Care
- Ruishikang China R&D Center
  - 研发中心 |上海
  - 研发中心 |武汉
- Product pipeline
Innovative Product
- Product List
- Medical Information
News Center
- Company News
- Ruishikang Annual Report
About Ruishikang
- Ruishikang Global
  - Global Overview
    Ruiyi Enterprising
  - Management team
    The highest leadership of the company
- Ruishikang China
  - Overview of Ruishikang
    Jointly Creating a Healthy China
  - Message from the President
    Listen to the voice of the CEO
- 责任
  - Corporate Governance
    Sustainable Development
  - Corporate Responsibility
    Excellent Corporate Citizen
- Career Development
  - Talent recruitment

中文 / EN

Home Page About Ruishikang Ruishikang Global Global Overview

Global management team

Dr. Albert Bourla
Chief Executive Officer and Chairman